Trulicity enhances the bodys natural ability to produce insulin in response to increased blood sugar levels
These diabetes treatments have become the weight loss phenomenon of the decade
For patients who have plateaued on semaglutide or who respond better to dual-agonist therapy, transitioning to a tirzepatide glycine B12 blend may provide the additional efficacy needed
The 0.9% benzyl alcohol concentration provides effective preservation without interfering with peptide stability
GLP-1 Safety in RA So far, GLP-1 receptor agonists appear to be generally safe in people with RA, though more research is needed, says Nancy Lane, MD, an endowed professor of medicine, rheumatology, and aging research at the University of California in Davis
In TRIUMPH-4 (obesity + knee OA): nausea 43%, diarrhea 33%, dysesthesia 20.9%